The phase out of and restrictions on per-and polyfluoroalkyl substances: Time for a rethink

By Ishmail Sheriff, Sisay Abebe Debela, Osman Alhaji Kabia, Charles Evrard Ntoutoume, and Matthew James Turay
Chemosphere
March 9, 2020
DOI: 10.1016/j.chemosphere.2020.126313

Industrial manufacture boom in the past decades had resulted in the release of new chemicals to the environment. A group of manmade chemicals called per-and polyfluoroalkyl substances (PFASs) are among these chemicals that have gained traction in recent years which are used in myriad consumer and industrial products worldwide. Since some PFASs are persistent, bioaccumulative, and toxic in nature, series of programs and regulatory initiatives have been introduced to end their production; and gradually replacing them with short chain alternatives. However, concerns have been expressed in the scientific literature about the characteristics and effects of some of these short chain alternatives on environmental and living systems. Here, we suggest that professional scientific bodies should be part of the review process of alternatives short chain PFASs, owing to their immeasurable contribution to knowledge and understanding of these chemicals. Per and poly fluoroalkyl substances are understudied and poorly regulated in developing countries. Therefore, in order for these countries to contribute meaningfully to the global regulatory initiatives on PFASs, transfer of technology and capacity building must be explicitly considered, given the developed competencies, technical expertise and skills that are required for evidence-based policy development and implementation. Furthermore, the issue of transparency of the production and use of PFASs which some companies consider as confidential business information (CBI) must be closely paid attention to by regulators. Confidential business information if not properly addressed may undermine regulatory and risk reduction measures as it may limit most of the relevant information pertaining to PFASs.

View on PubMed

Topics: